Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1.

Sharma MR, Auman JT, Patel NM, Grilley-Olson JE, Zhao X, Moschos SJ, Parker JS, Yin X, Hayward MC, Polite BN, Marangon E, Posocco B, Toffoli G, Hayes DN, Innocenti F.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.16.00015. Epub 2017 Apr 27.

PMID:
30009279
2.

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Sehdev A, Karrison T, Zha Y, Janisch L, Turcich M, Cohen EEW, Maitland M, Polite BN, Gajewski TF, Salgia R, Pinto N, Bissonnette MB, Fleming GF, Ratain MJ, Sharma MR.

Cancer Chemother Pharmacol. 2018 Jun 9. doi: 10.1007/s00280-018-3619-3. [Epub ahead of print]

PMID:
29948021
3.

A New Look at the State of Cancer Care in America.

Polite BN, Seid JE, Levit LA, Kirkwood MK, Schenkel C, Bruinooge SS, Grubbs SS, Kamin DY, Schilsky RL.

J Oncol Pract. 2018 Jul;14(7):397-399. doi: 10.1200/JOP.18.00150. Epub 2018 Jun 15. No abstract available.

PMID:
29906212
4.

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

Kirkwood MK, Hanley A, Bruinooge SS, Garrett-Mayer E, Levit LA, Schenkel C, Seid JE, Polite BN, Schilsky RL.

J Oncol Pract. 2018 Jul;14(7):e412-e420. doi: 10.1200/JOP.18.00149. Epub 2018 Jun 15.

PMID:
29906211
5.

Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.

Wellmann R, Borden BA, Danahey K, Nanda R, Polite BN, Stadler WM, Ratain MJ, O'Donnell PH.

Cancer. 2018 Jul 15;124(14):3052-3065. doi: 10.1002/cncr.31382. Epub 2018 May 9.

PMID:
29742281
6.

A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning.

Bestvina CM, Wroblewski KE, Daly B, Beach B, Chow S, Hantel A, Malec M, Huber MT, Polite BN.

J Palliat Med. 2018 Jun;21(6):846-849. doi: 10.1089/jpm.2017.0408. Epub 2018 Mar 13.

PMID:
29649399
7.

Impact on Oncology Practices of Including Drug Costs in Bundled Payments.

Ward JC, Levit LA, Page RD, Hennessy JE, Cox JV, Kamin DY, Bruinooge SS, Shih YT, Polite BN.

J Oncol Pract. 2018 May;14(5):e259-e268. doi: 10.1200/JOP.17.00036. Epub 2018 Apr 12.

PMID:
29648923
8.

An Update on Colorectal Cancer.

Xue L, Williamson A, Gaines S, Andolfi C, Paul-Olson T, Neerukonda A, Steinhagen E, Smith R, Cannon LM, Polite B, Umanskiy K, Hyman N.

Curr Probl Surg. 2018 Mar;55(3):76-116. doi: 10.1067/j.cpsurg.2018.02.003. Epub 2018 Feb 13. Review. No abstract available.

PMID:
29631699
9.

Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.

Polite BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, Cheng Y, Brewer KC, Rauscher GH, Fitchett GA.

Cancer. 2018 Jun 15;124(12):2578-2587. doi: 10.1002/cncr.31351. Epub 2018 Mar 26.

PMID:
29579340
10.

The Road From Theory to Reality: Illuminating the Complexity of Prospective Cancer Bundles.

Polite BN.

J Oncol Pract. 2018 Feb;14(2):59-61. doi: 10.1200/JOP.2017.029090. Epub 2018 Jan 18. No abstract available.

PMID:
29346022
11.

Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.

Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH.

Ann Epidemiol. 2017 Nov;27(11):731-738.e1. doi: 10.1016/j.annepidem.2017.10.006. Epub 2017 Oct 13.

PMID:
29173578
12.

Blase Polite on How Disparities Research Must Move Into an Era of Action.

Polite BN.

Oncology (Williston Park). 2017 Oct 15;31(10):709-10, 717. No abstract available.

13.

Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes.

Ibraheem A, Polite B.

Cancer. 2017 Dec 15;123(24):4752-4756. doi: 10.1002/cncr.31073. Epub 2017 Oct 26. No abstract available.

PMID:
29072791
14.

Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study.

de W Marsh R, Talamonti MS, Baker MS, Posner M, Roggin K, Matthews J, Catenacci D, Kozloff M, Polite B, Britto M, Wang C, Kindler H.

J Surg Oncol. 2018 Mar;117(3):354-362. doi: 10.1002/jso.24872. Epub 2017 Oct 16.

15.

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.

Pectasides E, Stachler MD, Derks S, Liu Y, Maron S, Islam M, Alpert L, Kwak H, Kindler H, Polite B, Sharma MR, Allen K, O'Day E, Lomnicki S, Maranto M, Kanteti R, Fitzpatrick C, Weber C, Setia N, Xiao SY, Hart J, Nagy RJ, Kim KM, Choi MG, Min BH, Nason KS, O'Keefe L, Watanabe M, Baba H, Lanman R, Agoston AT, Oh DJ, Dunford A, Thorner AR, Ducar MD, Wollison BM, Coleman HA, Ji Y, Posner MC, Roggin K, Turaga K, Chang P, Hogarth K, Siddiqui U, Gelrud A, Ha G, Freeman SS, Rhoades J, Reed S, Gydush G, Rotem D, Davison J, Imamura Y, Adalsteinsson V, Lee J, Bass AJ, Catenacci DV.

Cancer Discov. 2018 Jan;8(1):37-48. doi: 10.1158/2159-8290.CD-17-0395. Epub 2017 Oct 4.

PMID:
28978556
16.

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

Cancer Res. 2017 Sep 1;77(17):4548-4555. doi: 10.1158/0008-5472.CAN-17-0623. Epub 2017 Jul 24. No abstract available.

PMID:
28739629
17.

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

CA Cancer J Clin. 2017 Sep;67(5):353-361. doi: 10.3322/caac.21404. Epub 2017 Jul 24. No abstract available.

18.

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

J Clin Oncol. 2017 Sep 10;35(26):3075-3082. doi: 10.1200/JCO.2017.73.6546. Epub 2017 Jul 24. No abstract available.

PMID:
28737975
19.

Pursuing Value in Cancer Care: A Model in Progress.

Polite B, Walradt J.

J Oncol Pract. 2017 Jul;13(7):407-409. doi: 10.1200/JOP.2017.023648. Epub 2017 Jun 26. No abstract available.

PMID:
28650744
20.

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C.

JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105.

21.

Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer.

Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK.

Lancet Oncol. 2017 Jun;18(6):711-712. doi: 10.1016/S1470-2045(17)30336-4. No abstract available.

PMID:
28593843
22.

Implementation of Advance Care Planning in Oncology: A Review of the Literature.

Bestvina CM, Polite BN.

J Oncol Pract. 2017 Oct;13(10):657-662. doi: 10.1200/JOP.2017.021246. Epub 2017 Jun 6. Review.

PMID:
28586259
23.

Dynamic Equilibrium.

Nabhan A, Polite BN.

J Oncol Pract. 2017 Jun;13(6):345-347. doi: 10.1200/JOP.2016.020305. Epub 2017 Apr 17. No abstract available.

PMID:
28414556
24.

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ.

Clin Pharmacol Ther. 2017 Nov;102(5):859-869. doi: 10.1002/cpt.709. Epub 2017 Jun 15.

PMID:
28398598
25.

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.

Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C, Pasia M, Bland G, Ohinata A, Rogers J, Mehdizadeh A, Banks K, Lanman R, Wolff RA, Streicher H, Allison J, Sharma P, Eng C.

Lancet Oncol. 2017 Apr;18(4):446-453. doi: 10.1016/S1470-2045(17)30104-3. Epub 2017 Feb 18.

26.

Evaluating screening colonoscopy quality in an uninsured urban population following patient navigation.

Naylor K, Fritz C, Polite B, Kim K.

Prev Med Rep. 2016 Dec 27;5:194-199. doi: 10.1016/j.pmedr.2016.12.019. eCollection 2017 Mar.

27.

Reply to P.B. Bach.

Polite BN, Kamin DY, Grubbs SS.

J Clin Oncol. 2016 Dec 20;34(36):4448-4449. Epub 2016 Oct 31. No abstract available.

PMID:
27998228
28.

No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations.

Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN.

J Oncol Pract. 2016 Oct;12(10):e901-e911.

29.

Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer.

Toffoli G, Sharma MR, Marangon E, Posocco B, Gray E, Mai Q, Buonadonna A, Polite BN, Miolo G, Tabaro G, Innocenti F.

Clin Cancer Res. 2017 Feb 15;23(4):918-924. doi: 10.1158/1078-0432.CCR-16-1012. Epub 2016 Aug 9.

30.

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL.

J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31. No abstract available.

PMID:
27247218
31.

A Pathway Through the Bundle Jungle.

Polite B, Ward JC, Cox JV, Morton RF, Hennessy J, Page R, Conti RM.

J Oncol Pract. 2016 Jun;12(6):504-9. doi: 10.1200/JOP.2015.008789. Epub 2016 May 12. Review. No abstract available.

PMID:
27173604
32.

An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population.

Polite BN, Cipriano-Steffens T, Hlubocky F, Dignam J, Ray M, Smith D, Undevia S, Sprague E, Olopade O, Daugherty C, Fitchett G, Gehlert S.

J Racial Ethn Health Disparities. 2017 Apr;4(2):140-148. doi: 10.1007/s40615-016-0211-6. Epub 2016 Mar 16.

PMID:
26983622
33.

Oncology Pathways-Preventing a Good Idea From Going Bad.

Polite BN, Page RD, Nabhan C.

JAMA Oncol. 2016 Mar;2(3):297-8. doi: 10.1001/jamaoncol.2015.5778. No abstract available.

PMID:
26847876
34.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).

Lee AM, Shi Q, Alberts SR, Sargent DJ, Sinicrope FA, Berenberg JL, Grothey A, Polite B, Chan E, Gill S, Kahlenberg MS, Nair SG, Shields AF, Goldberg RM, Diasio RB.

Pharmacogenet Genomics. 2016 Mar;26(3):133-7. doi: 10.1097/FPC.0000000000000197.

35.

Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.

Raoul JL, Park JW, Kang YK, Finn RS, Kim JS, Yeo W, Polite BN, Chao Y, Walters I, Baudelet C, Lencioni R.

Liver Cancer. 2014 Oct;3(3-4):439-50. doi: 10.1159/000343872. Review.

36.

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.

O'Donnell PH, Karovic S, Karrison TG, Janisch L, Levine MR, Harris PJ, Polite BN, Cohen EE, Fleming GF, Ratain MJ, Maitland ML.

Clin Cancer Res. 2015 Nov 15;21(22):5092-9. doi: 10.1158/1078-0432.CCR-15-0427. Epub 2015 Jul 21.

37.

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, Stamos MJ, Ternent CA, Herzig DO, Fichera A, Polite BN, Dietz DW, Patil S, Avila K; Timing of Rectal Cancer Response to Chemoradiation Consortium.

Lancet Oncol. 2015 Aug;16(8):957-66. doi: 10.1016/S1470-2045(15)00004-2. Epub 2015 Jul 14.

38.

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL, American Society of Clinical Oncology.

J Clin Oncol. 2015 Aug 10;33(23):2563-77. doi: 10.1200/JCO.2015.61.6706. Epub 2015 Jun 22. No abstract available.

39.

Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.

Polite B, Conti RM, Ward JC.

Am Soc Clin Oncol Educ Book. 2015:e75-80. doi: 10.14694/EdBook_AM.2015.35.e75.

40.

Reply to M. Thompson et Al.

Polite B, Ward JC, Cox JV, Morton RF, Hennessy J, Page R, Conti RM.

J Oncol Pract. 2015 May;11(3):263-4. doi: 10.1200/JOP.2015.003897. Epub 2015 Mar 3. No abstract available.

PMID:
25736384
41.

Medicare innovation center oncology care model: a toe in the water when a plunge is needed.

Polite BN, Miller HD.

J Oncol Pract. 2015 Mar;11(2):117-9. doi: 10.1200/JOP.2014.002899. Epub 2015 Feb 17. No abstract available.

PMID:
25690595
42.

Eliminating racial disparities in colorectal cancer in the real world: it took a village.

Grubbs SS, Polite BN, Carney J Jr, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED.

Del Med J. 2014 Oct;86(10):301-5. No abstract available.

PMID:
25647858
43.

States as the laboratory for democracy: is anybody paying attention, and does anybody care?

Polite BN.

J Clin Oncol. 2015 Mar 10;33(8):815-6. doi: 10.1200/JCO.2014.59.4135. Epub 2015 Jan 20. No abstract available.

PMID:
25605832
44.

Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.

Sehdev A, Shih YC, Vekhter B, Bissonnette MB, Olopade OI, Polite BN.

Cancer. 2015 Apr 1;121(7):1071-8. doi: 10.1002/cncr.29165. Epub 2014 Nov 25.

45.

American Society of Clinical Oncology policy statement on medicaid reform.

Polite BN, Griggs JJ, Moy B, Lathan C, duPont NC, Villani G, Wong SL, Halpern MT.

J Clin Oncol. 2014 Dec 20;32(36):4162-7. doi: 10.1200/JCO.2014.56.3452. Epub 2014 Nov 17. No abstract available.

46.

Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.

Polite BN, Ward JC, Cox JV, Morton RF, Hennessy J, Page RD, Conti RM.

J Oncol Pract. 2014 Nov;10(6):357-62. doi: 10.1200/JOP.2014.001958. No abstract available.

47.

The role of statins for primary prevention in non-elderly colorectal cancer patients.

Sehdev A, Shih YC, Huo D, Vekhter B, Lyttle C, Polite B.

Anticancer Res. 2014 Sep;34(9):5043-50.

PMID:
25202089
48.

Achieving a deeper understanding of the implemented provisions of the Affordable Care Act.

Zhang SQ, Polite BN.

Am Soc Clin Oncol Educ Book. 2014:e472-7. doi: 10.14694/EdBook_AM.2014.34.e472. Review.

49.

Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies.

Salgia R, Patel P, Bothos J, Yu W, Eppler S, Hegde P, Bai S, Kaur S, Nijem I, Catenacci DV, Peterson A, Ratain MJ, Polite B, Mehnert JM, Moss RA.

Clin Cancer Res. 2014 Mar 15;20(6):1666-75. doi: 10.1158/1078-0432.CCR-13-2070. Epub 2014 Feb 3.

50.

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O'Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ.

J Clin Oncol. 2014 Jan 10;32(2):129-60. doi: 10.1200/JCO.2013.53.7076. Epub 2013 Dec 10.

PMID:
24327669

Supplemental Content

Loading ...
Support Center